2185 — Shanghai Bio-heart Biological Technology Co Balance Sheet

0.000.00%

Last trade - 00:00

Market Cap
HK$587.89m
Enterprise Value
HK$402.61m
Revenue

Annual balance sheet for Shanghai Bio-heart Biological Technology Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	454	709	451	369	202
Net Total Receivables	2.31	8.91	5.8	6.12	—
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	471	757	542	408	299
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.3	72.3	76	30.9	51.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	785	1,115	982	818	734
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13.9	36.8	28.8	20.1	19.6
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	85	119	98.3	69.5	73.3
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	700	996	883	748	660
Total Liabilities & Shareholders' Equity	785	1,115	982	818	734
Total Common Shares Outstanding